IP Library › Granted Patent US 10,813,972
Granted Patent B2
US 10,813,972 · App. 14/766,215 · Granted Oct 27, 2020

Treatment of DNA damage and mitochondrial dysfunction using palm fruit juice

Inventors: Adam E. Osborne (Waltham, MA); Lawrence J. Wangh (Auburndale, MA); Kenneth C. Hayes (Wellesley Hills, MA); Ravigadevi Sambanthamurthi (Petaling Jaya, MY)
Assignees: MALAYSIAN PALM OIL BOARD; BRANDEIS UNIVERSITY
A61K36/889A23L33/105A61K31/192A61K31/4409A61K31/7072C12Q1/6883G01N33/6842A23V2002/00C12Q2600/156
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,813,972
App. No.
14/766,215
Granted
Oct 27, 2020
Kind
B2
Abstract

Methods, compositions and kits for the prevention and treatment of mitochondrial dysfunction, mitochondrial DNA damage and genomic DNA damage are provided. The methods use the administration of palm fruit juice and/or compositions containing phenolic compounds present in palm fruit juice. The methods, compositions, and kits can be used to reduce DNA damage in subjects being treated with nucleoside reverse transcriptase inhibitors, such as patients having HIV or AIDS.

Claims (9)

1. A method of treating or preventing mitochondrial dysfunction in a subject who has been administered a nucleoside reverse transcriptase inhibitor (NRTI) or isoniazid, the method comprising administering to the subject a composition containing a water soluble extract from a fruit of genus Elaeis or one or more phenolic compounds present in a water soluble extract from a fruit of genus Elaeis.

2. A method of treating or preventing mtDNA damage in a subject who has been administered a nucleoside reverse transcriptase inhibitor (NRTI) or isoniazid, the method comprising administering to the subject a composition comprising a water soluble extract from a fruit of genus Elaeis or one or more phenolic compounds present in a water soluble extract from a fruit of genus Elaeis.

3. The method of claim 1 , further comprising administering an NRTI to the subject.

4. The method of claim 1 , wherein the NRTI is 3′-azido-3′-deoxythymidine (AZT).

5. The method of claim 1 , wherein the NRTI inhibits mitochondrial polymerase γ.

6. The method of claim 1 , wherein the NRTI increases the rate of mitochondrial DNA mutations.

7. The method of claim 1 , wherein administration of the composition comprising a water soluble extract from a fruit of genus Elaeis or one or more phenolic compounds present in a water soluble extract from a fruit of genus Elaeis decreases the rate of mitochondrial DNA mutations.

8. The method of claim 1 , wherein one or more phenolic compounds present in a water soluble extract from a fruit of genus Elaeis is administered, and said one or more phenolic compounds are natural or synthetic.

9. The method of claim 1 , further comprising determining whether the subject has a mitochondrial DNA mutation.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 6, 2015
From: OSBORNE, ADAM E.; WANGH, LAWRENCE J.; HAYES, KENNETH C.
To: BRANDEIS UNIVERSITY
Reel/Frame 036268/0809 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 6, 2015
From: SAMBANTHAMURTHI, RAVIGADEVI
To: MALAYASIAN PALM OIL BOARD
Reel/Frame 036268/0850 →
Continuity (3)
Provisional Application 61761473 · Feb 6, 2013
Provisional Application 61791162 · Mar 15, 2013
Related Publication 20160000854A1 · Jan 7, 2016